Article citationsMore>>

M. Kaplan, E. Beutler, H. J. Vreman, C. Hammerman, E. Levy-Lahad, P. Renbaum, et al., “Neonatal Hyperbiliru- Binemia in Glucose-6-Phosphate Dehydrogenase Deficient Heterozygotes,” Pediatrics, Vol. 104, No. 1, Part 1, 1999, pp. 68-74.

has been cited by the following article:

• TITLE: Prevalence of Glucose-6-Phosphate Dhydrogenase Deficient Neonates and Cost Effective of Enzyme Screening in Tehran, Iran

  AUTHORS: Hossein Dahifar, Aboulfazl Ghorbani, Manijeh Ghods

  KEYWORDS: Screening, Newborns, G-6-PD

  JOURNAL NAME: Chinese Medicine, Vol.1 No.2, November 2, 2010

  ABSTRACT: Background: Newborn screening is an area with potential for immense impact in lifelong morbidity and mortality. Objective: To determine cost effective for glucose-6-phosphate dehydrogenase (G-6-PD) enzyme screening and prevalence of deficiency in newborns and children in Tehran, Iran. Materials and Methods: All full term newborns, neonates with icterus and children with acute hemolysis were evaluated to determine prevalence of G-6-PD enzyme deficiency and cost effectiveness of a screening test for G-6-PD enzyme deficiency. The qualitative color reduction test performed on healthy newborns and quantitative test on newborns with icterus and children with acute hemolysis. Results: Three (2%) of 146 screened newborns were G-6-PD deficient at a cost of $ 18 for three positive screening tests and $ 856 for 143 unaffected newborns Thirty-one (11.4%) of 272 newborns readmitted with icterus were G-6-PD deficient with a cost of 31 tests were $186 and $1446 for unaffected newborns. The only significant difference between G-6-PD deficient and normal newborns was bilirubin level (p